• Genexine canceled its 3 billion won third-party allotment capital increase on Oct. 26, 2026, because the allottee failed to pay.
• Korea Quantum AI notified it could not complete payment by the deadline, despite completing its subscription on Oct. 20, 2026.
• The offering comprised 1,250,500 new common shares at 2,399 won each, all allocated to Korea Quantum AI.
• The capital increase, initially authorized on Oct. 16, 2026, was intended to fund working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genexine Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261026900740), on October 26, 2026, and is solely responsible for the information contained therein.